Maofu Fu
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
- Oncology 17
- Cancer-related Molecular Pathways 16
-
- Histone Deacetylase Inhibitors Research 10
- Ubiquitin and proteasome pathways 9
- Cancer-related gene regulation 7
- Genomics and Chromatin Dynamics 6
- Epigenetics and DNA Methylation 6
- Cell death mechanisms and regulation 5
- Co-authors
- Richard G. Pestell (43 shared papers)Chenguang Wang (20 shared papers)Zhiping Li (8 shared papers)Toshiyuki Sakamaki (5 shared papers)Chris Albanese (16 shared papers)Xueping Zhang (8 shared papers)Anne T. Reutens (6 shared papers)Michael P. Lisanti (9 shared papers)
- Journals
- Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (9 papers)Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Maofu Fu
44 papers receiving 6.0k citations
Maofu Fu's Hit Papers
Peers
Comparison fields: 5 of 112
- Geriatrics and Gerontology 492
- Oncology 1.7k
- Cancer Research 932
- Molecular Biology 4.1k
- Cell Biology 679
Countries citing papers authored by Maofu Fu
This map shows the geographic impact of Maofu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maofu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maofu Fu more than expected).
Fields of papers citing papers by Maofu Fu
This network shows the impact of papers produced by Maofu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maofu Fu. The network helps show where Maofu Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Maofu Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Minireview: Cyclin D1: Normal and Abnormal Functions Hit paper breakdown → | 2004 | 829 |
| 2 | 2000 | 338 | |
| 3 | 2000 | 318 | |
| 4 | 2001 | 299 | |
| 5 | 2005 | 298 | |
| 6 | 1999 | 260 | |
| 7 | 2005 | 242 | |
| 8 | 2003 | 228 | |
| 9 | 2000 | 218 | |
| 10 | 2006 | 204 | |
| 11 | 2001 | 187 | |
| 12 | 2003 | 180 | |
| 13 | 2006 | 178 | |
| 14 | 1999 | 168 | |
| 15 | 2001 | 159 | |
| 16 | 2006 | 156 | |
| 17 | 2006 | 155 | |
| 18 | 2004 | 153 | |
| 19 | 2001 | 151 | |
| 20 | 2002 | 145 |
About Maofu Fu
Maofu Fu is a scholar working on Oncology, Molecular Biology, Geriatrics and Gerontology, Cancer Research and Cell Biology, having authored 44 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), Histone Deacetylase Inhibitors Research (10 papers), Ubiquitin and proteasome pathways (9 papers), Cancer-related gene regulation (7 papers), Genomics and Chromatin Dynamics (6 papers), Epigenetics and DNA Methylation (6 papers), Cell death mechanisms and regulation (5 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Geriatrics and Gerontology (492 citations), Oncology (1.7k citations), Cancer Research (932 citations), Molecular Biology (4.1k citations) and Cell Biology (679 citations). Maofu Fu has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Richard G. Pestell, Chenguang Wang, Zhiping Li, Toshiyuki Sakamaki, Chris Albanese, Xueping Zhang, Anne T. Reutens, Michael P. Lisanti, Anthony A. Sauve and Toula Bouras. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Cancer Research, Proceedings of the National Academy of Sciences and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.